Correlation Between FibroGen and Eli Lilly

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both FibroGen and Eli Lilly at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining FibroGen and Eli Lilly into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between FibroGen and Eli Lilly and, you can compare the effects of market volatilities on FibroGen and Eli Lilly and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in FibroGen with a short position of Eli Lilly. Check out your portfolio center. Please also check ongoing floating volatility patterns of FibroGen and Eli Lilly.

Diversification Opportunities for FibroGen and Eli Lilly

-0.06
  Correlation Coefficient

Good diversification

The 3 months correlation between FibroGen and Eli is -0.06. Overlapping area represents the amount of risk that can be diversified away by holding FibroGen and Eli Lilly and in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Eli Lilly and FibroGen is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on FibroGen are associated (or correlated) with Eli Lilly. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Eli Lilly has no effect on the direction of FibroGen i.e., FibroGen and Eli Lilly go up and down completely randomly.

Pair Corralation between FibroGen and Eli Lilly

Assuming the 90 days trading horizon FibroGen is expected to under-perform the Eli Lilly. In addition to that, FibroGen is 4.17 times more volatile than Eli Lilly and. It trades about -0.04 of its total potential returns per unit of risk. Eli Lilly and is currently generating about 0.1 per unit of volatility. If you would invest  755,642  in Eli Lilly and on September 24, 2024 and sell it today you would earn a total of  786,558  from holding Eli Lilly and or generate 104.09% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

FibroGen  vs.  Eli Lilly and

 Performance 
       Timeline  
FibroGen 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days FibroGen has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, FibroGen is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
Eli Lilly 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Eli Lilly and has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

FibroGen and Eli Lilly Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with FibroGen and Eli Lilly

The main advantage of trading using opposite FibroGen and Eli Lilly positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if FibroGen position performs unexpectedly, Eli Lilly can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eli Lilly will offset losses from the drop in Eli Lilly's long position.
The idea behind FibroGen and Eli Lilly and pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.

Other Complementary Tools

Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities